Login / Signup

Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients.

Lucas BouysAnna VaczlavikAnne JouinotPatricia VaduvaStéphanie EspiardGuillaume AssiéRossella LibéKarine PerlemoineBruno RagazzonLaurence GuignatLionel GroussinLéopoldine BricaireIsadora Pontes CavalcanteFidéline Bonnet-SerranoHervé LefebvreMarie-Laure Raffin-SansonNicolas ChevalierPhilippe A TouraineChristel JublancCamille VatierGerald RaverotMagalie HaissaguerreLuigi MaioneMatthias KroissMartin FassnachtSophie Christin-MaitreEric PasmantFrançoise Borson-ChazotAntoine TabarinMarie-Christine VantyghemMartin ReinckePeter KamenickỷMarie-Odile NorthJérôme Bertherat
Published in: European journal of endocrinology (2022)
We report the largest series of index patients investigated for ARMC5 and confirm that ARMC5 pathogenic variants are associated with a more severe phenotype in most cases. To minimize negative ARMC5 screening, genotyping should be limited to clear bilateral adrenal involvement and autonomous cortisol secretion, with an optimum sensitivity for routine clinical practice. These findings will also help to better define PBMAH diagnostic criteria.
Keyphrases
  • clinical practice
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • copy number
  • genome wide
  • gene expression
  • case report
  • patient reported outcomes
  • single cell
  • patient reported
  • atomic force microscopy